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a b s t r a c t 
The pathogenesis of mental disorders remains poorly understood and there are enormous challenges in the de- 
velopment of biomarkers and more effective therapeutic options. 
A total of 13 pairs of 26 siblings discordant for mental disorders, affected and unaffected, were subjected to Best 
Estimate Diagnosis process and clinical assessments with respect to their diagnosis, current mental health status 
and disability, resilience, medication, lifestyle and diet. All participants were of Hispanic ethnicity and residents 
of the San José Greater Metropolitan Area. Many of the pairs of siblings shared households. Affected individuals 
displayed major depression, bipolar affective disorder, psychosis non-otherwise specified or schizoaffective dis- 
order. In a subsequent analysis the affected individuals were further divided according to whether they exhibited 
psychotic features or not. 
Fecal samples were collected for the analysis of the gut microbiota using 16S rRNA gene amplicon sequencing 
and imputed metagenomics that were compared within the sibling pairs. Based on beta-diversity analysis, the 
use of levothyroxine and irbesartan was identified and thus used as confounders. Decreased bacterial richness 
was observed among the affected participants. The relative abundances of several bacterial taxa showed sig- 
nificant differences, including families Peptostreptococcaceae, Ruminococcaceae, Porphyromonadaceae , and genera 
Pseudomonas, Barnesiella, Odoribacter, Paludibacter, Lactococcus, Clostridium, Acidaminococcus and Haemophilus. 
The proportion of Proteobacteria ( Pseudomonas ) was significantly increased in the affected individuals, while 
the bacterial taxa associated to healthy phenotype, such as Barnesiella and Ruminococcaceae, were depleted in 
individuals affected with psychosis in comparison to those without psychosis. Based on prediction functions of 
the gut microbiota, significant alternations were found in the pathways associated with amino acid metabolism 
in affected individuals in comparison to the unaffected. 
Our findings suggest the changes in gut microbiota composition and functionality are associated with mental 


























The present study focuses on individuals with mood disorders or
ith psychosis. Psychosis is a clinical syndrome defined in the Diag-
ostic Statistical Manual V (DSM-V) by the presence of delusions, hallu-
inations, disorganized thinking, grossly disorganized or abnormal mo-
or behavior and negative symptoms ( American Psychiatric Association
013 ). Examples of negative symptoms are diminished emotional ex-
ression, avolition, or social withdrawal ( American Psychiatric Associa-
ion 2013 ). This syndrome is a common manifestation in several psychi-∗ Corresponding author at: Human Microbiome Research Program, Faculty of Med
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tric disorders such as major depressive disorder with psychosis, bipolar
isorder type I with psychosis, schizoaffective disorder and schizophre-
ia ( Arciniegas 2015 ). Most of these disorders are ranked among the
op causes of years lived with disability worldwide ( Global Burden of
isease Study 2015 ). Psychiatric disorders are of multifactorial etiol-
gy where both genetic and environmental factors have been impli-
ated with a particular focus on a possible autoimmune pathophysiology
 Girgis et al., 2014 ; Al-Diwani et al., 2017 ). In the history of psychiatry,
t has long been known that psychiatric disorders “run in families ” and
arly studies did indeed document the heritability of disorders such as January 2021 
ticle under the CC BY-NC-ND license 























































































































p  chizophrenia or bipolar disorder ( Sullivan et al., 2018 ). It is worth not-
ng that there is a shared genetic background between several disorders
uch as major depressive disorder, schizophrenia and bipolar disorder
 Anttila et al., 2018 ) and that clinical diagnoses do not reflect with exac-
itude the biological pathophysiology of each ( Tamminga et al., 2017 ).
fforts directed toward defining clearer mechanisms that explain the
athophysiology of mental disorders, biologically based diagnoses and
ovel treatments are greatly needed ( Tamminga et al., 2017 ). 
The study of a multifactorial condition, like mental disorders, re-
uires the investigation of both genetic and environmental contribu-
ors to the pathophysiology. The microbiota is metabolically compara-
le to an organ that is malleable and sensitive to both host (genetic)
 Blekhman et al., 2015 ) and environmental ( McDonald et al., 2018 )
ues. Microbes associated with the human body include eukaryotes, ar-
haea, bacteria and viruses and their communities together with their
enes are known as the human microbiome ( Methé et al., 2012 ). The
omposition of its ecosystems has implications in health and disease
 Knight et al., 2017 ). It has now been researched that among its func-
ions there is the harvest of inaccessible nutrients and synthesis of vita-
ins, the metabolism of xenobiotics, the renewal of gut epithelial cells,
he participation in the development and activity of the immune system
nd functions in behavior ( Turnbaugh et al., 2007 ). 
Growing attention has been recently paid to the evidence support-
ng a role played by the gut microbiota in the pathogenesis of severe
ental disorders in humans ( Nguyen et al., 2018 ; Petra et al., 2015 ;
emani et al., 2015 ; Dinan and Cryan, 2015 ). Through endocrino-
ogic, neurologic, metabolic and immunologic pathways the micro-
iota and brain communicate bidirectionally ( Dinan and Cryan, 2015 ;
nglin et al., 2015 ; Fond et al., 2016 ; Flowers and Ellingrod, 2015 ),
orming the microbiota-gut-brain axis ( Cryan and Dinan, 2012 ). A better
nderstanding of the microbiota-gut-brain axis may lead to the develop-
ent of novel biomarkers ( Mancabelli et al., 2017 ), or treatment options
hat target the gut microbiota through modulation or supplementation
r pharmacologically with psychobiotics ( Dinan et al., 2013 ). 
The microbiota communicates with the brain in several ways: it can
ecrete substances to the blood stream, it can induce immune cells to
roduce cytokines or it can alter signal transmission in the enteric or
n the autonomic nervous system. Bacteria affect the production of sev-
ral neurotransmitters, such as tryptophan, serotonin and kyneurenin
 Anglin et al., 2015 ). Furthermore, the bacteria themselves can produce
eurotransmitters such as norepinephrine, dopamine, serotonin, GABA,
cetyl-choline or histamine ( Flowers and Ellingrod, 2015 ). The brain, in
ts turn, influences the microbiota through the hypothalamic-pituitary-
drenal axis and the secretion of cortisol as well as sympathetic trans-
ission, vagal transmission and their consequent changes in intestinal
otility through gastroenteric secretions and changes in the production
f mucin ( Anglin et al., 2015 ) . The study of the microbiota-gut-brain
xis can have several potential translational applications ranging from
ts use as a biomarker ( Mancabelli et al., 2017 ) to modulating it phar-
acologically with the use of psychobiotics ( Dinan et al., 2013 ). 
The effects of the gut microbiota on behavior and cognition have
een demonstrated in studies using germ-free animals which docu-
ented altered functioning of the hypothalamic-pituitary-adrenal axis
nd deficits in working memory tasks, as well as in studies using agents
argeting the microbiota, such as probiotics, antibiotics or studies of
nfections ( Cryan and Dinan, 2012 ). Most current studies in humans
re observational case-control studies that have been recently reviewed
 Järbrink-Sehgal and Andreasson, 2020 ). For major depressive disor-
er, a systematic review and meta-analysis additionally concluded that
everal common taxa were reduced in the patients’ gut microbiota and
he six included probiotic interventions reduced depressive symptoms
 Sanada et al., 2020 ). a  
2 Differences in the microbiota have been documented in studies of
tress and anxiety and of autism spectrum disorders ( Sherwin et al.,
016 ). In addition to the comparative case-control studies, some other
roups have focused on studying the effect of antipsychotic drugs
 Hu et al., 2019 ; Flowers et al., 2019 ; Flowers et al., 2017 ; Pe ł ka-
ysiecka et al., 2019 ; Gorbovskaya et al., 2019 ) or of electroconvul-
ive therapy ( Kanayama et al., 2019 ) on the gut microbiota while other
roups have explored the applicability of measuring the abundance of
icrobial taxa as a biomarker for bipolar disorder ( Hu et al., 2019 ;
hen et al., 2018 ; Zheng et al., 2019 ) with promising results. Finally,
he use of probiotics as treatment has been explored in clinical tri-
ls also with promising results in bipolar disorder and schizophrenia
 Okubo et al., 2019 ; Aizawa et al., 2019 ; Reininghaus et al., 2018 ;
agamine et al., 2018 ). 
The recent studies that address this question specifically in bipo-
ar disorder and schizophrenia have been reviewed elsewhere in early
018 Nguyen et al., 2018 and in early 2019 T.T. Nguyen et al., 2019 .
t the time when the first review was conducted there were 10 stud-
es about either the microbiota or microbial translocation in these two
ypes of disorders. In this first review the authors additionally included
ve studies about bacterial translocation. In the second review they did
ot include studies about bacterial translocation and included 16 stud-
es in total. Two studies looked at the oropharyngeal microbiome of
chizophrenia. Eight studies found compositional and diversity differ-
nces in bipolar disorder. Two studies found differences in cases of first
pisode psychosis. In addition, there are two studies that have focused
n schizophrenia and have also found significant differences. Finally,
wo studies have looked at the microbiota of bipolar disorder in a pop-
lation of twins. One used only one pair of twins ( Jiang et al., 2019 )
hile Vinberg et all studied 128 monozygotic twins and found that high-
isk twins had lower alpha diversity and absence of Christencenellaceae
 Vinberg et al., 2019 ). 
While previous studies show differences in the gut microbiota be-
ween the affected and non-affected individuals, the implicated taxa
nd their directionality largely vary ( T.T. Nguyen et al., 2019 ). This
an be due to differences between the clinical phenotyping or methods
sed for microbiota analysis, or failure to consider co-variates such as
iet, medication, or smoking, thus potentially confounding the analy-
is. The present study selected gender and age matched cases and con-
rols among siblings to account for genetic, lifestyle and environmental
ariation, and conducted thorough clinical and dietary assessments in
arallel to the gut microbiota analysis. Our aim is to ask whether the
ut microbiota of individuals affected with severe mental disorders is
ifferent from that of their healthy siblings. 
. Materials, subjects, and methods 
.1. Study subjects and design 
.1.1. Ethics statement 
This study was approved by the Ethics Committee of the University
f Costa Rica. All participants provided informed consent and signed a
ritten informed consent form prior to their participation. 
.1.2. Participants 
The Psychiatric Genetics research group of the Cellular and Molecu-
ar Biology Research Centre of the University of Costa Rica has recruited
housands of individuals for genetic studies over the years. These indi-
iduals have been evaluated for an accurate psychiatric diagnosis and
everal samples are stored from them (p.e. serum samples or induced
luripotent stem cell lines). From these previously recruited individu-
ls, we recruited 37 subjects for the present study. They were all adults
















































































































i  iving in the Central Valley of Costa Rica in the Greater Metropolitan
rea of San José and, as per previous studies ( Contreras et al., 2008 ;
acheco et al., 2010 ) either diagnosed with a mental disorder or first-
egree family members of someone with a mental disorder. In the origi-
al study, individuals were excluded if they were younger than 18 years
r if they had either a learning disability or dementia. For this study, the
7 individuals were visited in their homes and asked to answer a ques-
ionnaire and provide a fecal sample. For the analysis, a subset of 26 par-
icipants, the “paired ” subset, was selected by strict matching between
ffected and unaffected siblings. When there were several possible sib-
ings that could be matched, we used criteria of gender and age for the
nal pairing. 
.2. Best estimate diagnosis 
In the previous studies in which they had participated, the research
ubjects had undergone a Best Estimate Diagnosis (BED) procedure,
his procedure has been described elsewhere ( Contreras et al., 2009 ).
rained psychiatrists blind to previous diagnoses applied the Diagnostic
nterview for Genetic Studies (DIGS) ( Nurnberger et al., 1994 ) to each
ubject and in parallel trained psychologists applied the Family Inter-
iew for Genetic Studies (FIGS) ( Diaz De Villalvilla Ramon et al., 2008 )
o a member of the family of the given subject. Afterwards, two other in-
ependent psychiatrists analyzed the information from both interviews
nd, when relevant, from medical records and then, together, reached a
onsensus diagnosis. The diagnoses were based on the DSM-IV diagnos-
ic criteria. 
.3. Clinical assessment 
The individuals answered a questionnaire designed by the Ameri-
an Gut Project ( McDonald et al., 2018 ) about their habits and diet.
urthermore, they answered the Saltin Grimby scale for Physical Ac-
ivity Level ( Grimby et al., 2015 ), the Connor-Davidson ( Connor and
avidson, 2003 ) scale for resilience, the WHO Disability Schedule
.0 Disability and Schedule, 2017 (WHODAS 2.0), they underwent
 physical examination of their musculoskeletal system and they an-
wered the Schedule for Affective Disorders and Schizophrenia (SADS-C)
 Endicott and Spitzer, 1978 ). Their weight, height and waist circumfer-
nce were also measured. The body mass index (BMI) was calculated
y dividing the weight in kilograms by the square of the height in me-
ers. They were also asked about all regular medication as well as their
onthly income. 
.4. Fecal sample collection and DNA purification from feces 
Fresh fecal samples were collected, transported in ice and frozen
s fast as possible and stored at − 80 °C until analysis. The DNA was
xtracted using the 12,888–100 DNeasy PowerSoil Kit by QIAGEN
 QIAGEN 2019 ). The purified DNA was subjected to concentration mea-
urement by a Qubit R ○ fluorometer (Invitrogen, CA 92,008, USA) and
tored at − 20 °C until further use. 
.5. Sequencing and preprocessing of the sequences 
Illumina MiSeq sequencing of hypervariable V3-V4 regions of the
6S rRNA gene was performed according to the manual for Illumina
ith a slight modification where dual index Truseq-tailed 1-step am-
lification ( Raju et al., 2018 ) was used for preparation. The pooled li-
raries were sequenced with an Illumina MiSeq instrument using MiSeq
3 reagent kit (2 × 300 bp) with 5% PhiX as spike-in at the sequencing
nit of the Institute for Molecular Medicine Finland (FIMM), Helsinki,
inland. The forward reads were truncated to length of 150 bases with
ProcessReads ” command or R package mare ( Korpela, 2016 ), where the3 efault settings for minimum quality score (2) and maximum expected
rrors (1) were applied. Reads with prevalence below 0.01% were re-
oved. Truncated, filtered and dereplicated reads were annotated us-
ng the Silva database ( Yilmaz et al., 2014 ). The median high-quality
equence per sample after preprocessing was 7097 (range 2331–9398).
.5.1. Study groups 
The selected 13 pairs of siblings were first divided into two groups:
ffected (A) or unaffected (U) according to the presence or absence of
n axis I psychiatric disorder. The subjects were further divided into
hree groups: unaffected (UA), affected without psychosis (AA) and af-
ected with psychosis (AP). The diagnoses of bipolar disorder type II,
ipolar disorder type I without psychosis and major depressive episode
ithout psychosis, were classified as “affected without psychosis ” and
hose of bipolar disorder type I with psychosis, bipolar disorder non-
therwise specified, major depressive episode with psychosis, psychosis
on-otherwise specified and schizoaffective disorder were classified as
affected with psychosis ”. 
Gut microbiota analyses 
All analyses were performed without rarefaction or data transfor-
ations. To account for the varying sequencing depth, the number of
eads per sample was used as an offset in all statistical models. P-values
enerated from multiple comparison were adjusted using the Benjamini-
ochberg method for false discovery rates (FDR). FDR-adjusted p-values
 0.1 were considered significant and reported in the text. All analyses
ere performed in R Team, 2018 using RStudio ( RStudio Team, 2020 ).
.5.2. Identification of confounding variables 
Permutational multivariate analysis of variance (PERMANOVA; ado-
is function in the vegan package ( Oksanen et al., 2019 )) based on the
ray-Curtis distance was used to identify factors that explain the varia-
ion in the microbiota, using all available background variables from
he questionnaires. The R function “GroupTest ” in the package mare
 Korpela, 2016 ), which utilizes a negative binomial generalized linear
odel, was further used for differential abundance testing of individual
acterial taxa. The factors were subsequently considered as potential
onfounders if the same bacterial taxa appeared to be influenced by
oth the factors and mental disorders. 
.5.3. Comparison of the gut microbiota composition, richness, and 
iversity 
The paired siblings were grouped in two (A and U, both N = 13) or
hree categories (UA; N = 13, AA N = 4 and AP; N = 9). When grouping in
hree categories, both AA and AP were compared to UA. The GroupTest
unction in mare was used to test differential abundances of the bacterial
enera and families between the study groups adjusting for the selected
onfounders. The differences in alpha diversity and richness were tested
sing an analysis of variance (ANOVA). 
.6. Imputed metagenomic analysis 
Bacterial metagenome content was predicted from 16S rRNA
ene-based microbial compositions. Functional inferences were made
rom the Kyoto Encyclopedia of Gene and Genomes (KEGG) catalog
 Kanehisa et al., 2012 ) using PICRUSt2 ( Douglas et al., 2019 ). The “DE-
eq ” function in DESeq2 ( Love et al., 2014 ) was used to test for differ-
ntially abundant KEGG pathways between study groups adjusting for
he use of levothyroxine and irbesartan as confounders. 
. Results 
.1. Basic characteristics of study participants 
We recruited 37 individuals, all of Hispanic ethnicity and residing
n the Greater Metropolitan Area of San José, Costa Rica. Initially they
S. Ouabbou, C. Jian, A. Ávila-Aguirre et al. Journal of Affective Disorders Reports 4 (2021) 100081 
Table 1 
Psychiatric diagnoses of the participants after matching siblings. 
Diagnosis Number of participants Presence of psychosis 
No axis I diagnosis 13 No 
Major Depressive Episode with psychotic features 1 Yes 
Schizoaffective Disorder – Bipolar Type 2 Yes 
Bipolar Affective Disorder, Type I with psychotic features 5 Yes 
Bipolar Affective Disorder, Type I (without psychotic features) 3 No 
Bipolar Affective Disorder – non otherwise specified 1 Yes 




















































Fig. 1. Composition of the microbiota, shown as mean abundance of abundant 
genera, of the participants by groups unaffected (0), affected without psychosis 


























p  omprised 22 individuals affected of a mental disorder and 15 unaf-
ected controls who were first degree relatives of the affected partici-
ants. We then matched the participants to have one affected sibling
aired with one healthy control sibling. This matching left us with 13
airs of 26 siblings whose characteristics are summarized in Table 1 of
he supplement. Of these, 8 individuals (four pairs) lived in the same
ousehold and 10 individuals (5 pairs) were neighbors. Their median
ge was of 56.5 years with a minimum of 37 and a maximum of 72
ears. A total of 18 participants (69%) were women and 21 (80.8%)
ere not engaged in gainful activity or were responsible for domestic
hores. Participants had different educational backgrounds, 15 of them
ad 6 or less years of formal education, 6 had 7–12 years and 5 had
igher education. Only one affected individual smoked daily, the rest
id not smoke. The mean BMI was of 29.9 with a minimum of 22 and
 maximum of 42. The median income per capita was of 235 United
tates Dollars (USD) per month with a minimum of 13 and a maximum
f 1176. Their diagnoses are summarized in Table 1 . There were several
o-morbidities: 7 individuals had diabetes mellitus type II, 11 suffered
rom hypothyroidism of which one was thyroidectomized for history
f Hashimoto’s thyroiditis, one unaffected sibling had Wilson’s disease
Supplementary Table 2). The use of prescription drugs is listed in Sup-
lementary Table 3. 
Beta diversity assessment of the gut microbiota 
To screen for potential confounders, we used PERMANOVA for
eta diversity (i.e. between-samples distance) comparisons using all
he available background variables among the whole data set of 37
ndividuals. We found that three variables were significantly associ-
ted to beta-diversity: use of levothyroxine (R2 = 0.065, p = 0.005),
se of irbesartan (R2 = 0.068, p = 0.001) and birth by cesarean section
R2 = 0.057, p = 0.017). All other variables tested, including age, an-
hropometric measurements, use of psychoactive drugs (including an-
ipsychotics), use of metformin, family identification number and di-
tary variables, were not significantly associated with the microbiota
ariation ( p > 0.05). Based on the results, statistical analyses were ad-
usted for the use of levothyroxine and irbesartan. C-section birth was
ot used as confounder as only four individuals (two affected and two
naffected) were born by cesarean section and genus-level analysis in-
icated there was no overlap between the implicated taxa and those
ffected by the mental disorder status. The mental disorder status was
ot significantly associated to beta diversity ( p = 0.809 and 0.743 for
 and 3 group comparisons respectively) and neither was the family ID
 p = 0.735). 
.2. Analysis of compositional differences in the gut microbiota 
Among the 26 individuals, Firmicutes dominated the subjects’ micro-
iota (60%), followed by Bacteroidetes (28%), Verrucobacteria (22%),
ctinobacteria (8%), Proteobacteria (5%) and the rest represented less
han 1%. At the genus level, the ten most abundant genera were
achnospiraceae IncertaeSedis (14.6%), Prevotella (10.1%), Bacteroides
10.0%), Faecalibacterium (4.8%), Blautia (4.5%), Ruminococcus 4.2%),
ncultured Christensenellaceae (3.1%), Enterobater (2.9%), Megasphaera
2.6%), and Collinsella (2.5%). Fig. 1 shows a composite plot for the
bundant taxa stratified into three groups ( Fig. 1 ). 4 .2.1. Siblings classified into affected or unaffected 
The proportions of Peptostreptococcaceae ( p = 0.086, fold
hange = 0.27) and Pseudomonadaceae ( p = 0.086, fold change = 18.62)
ere significantly decreased and increased, respectively, in the affected
ndividuals (Supplementary Table 4). At the genus level, the relative
bundances of several bacterial taxa were reduced in the affected indi-
iduals, Barnesiella ( p = 4.11 × 10 − 6 , fold change = 0.15), IncertaeSedis
eptostreptoccocaceae ( p = 0.053, fold change = 0.29), Ruminococ-
aceae IncertaeSedis ( p = 0.080, fold change = 0.43), Acidaminococcus
 p = 7.59 × 10 − 10 , fold change = 0.42). Megasphaera ( p = 4.28 × 10 − 67 ,
old change = 1.82) and Pseudomonas ( p = 0.076, fold change = 18.62)
ere significantly enriched in the affected individuals ( Fig. 2 ). 
.2.2. Siblings classified into unaffected, affected without psychosis and 
ffected with psychosis 
Several significant differences in the relative abundance of bacterial
amilies and genera were observed when comparing the microbiota of
he two affected study groups -affected without psychosis and affected
ith psychosis- to unaffected (Supplementary Table 5), including Por-
hyromonadaceae (reduced AP p = 0.017, fold change = 0.31), Strepto-
occaaceaetococcaaceae (AA p = 0.054, FC = 0.13), Clostridiaceae (AP
 = 0.019, FC = 0.019), Peptostreptococcaceae (AP p = 0.052, FC = 0.5)
nd Pasterurellaceae (AA p = 0.054, FC = 0.035) at the family level. At the
enus level, as shown in Fig. 3 , these differences were significant for Bar-
esiella (AA p = 0.078, AP p = 6.72 × 10 − 7 ), Odoribacter (AP p = 0.018;
C = 0.15) and Paludibacter (AA p = 0.078, FC = 26.05), Lactococcus (AP
 = 0.025, FC = 5.72), Clostridium (AP p = 0.021, FC = 0.25), Peptostrep-
S. Ouabbou, C. Jian, A. Ávila-Aguirre et al. Journal of Affective Disorders Reports 4 (2021) 100081 
Fig. 2. Compositional differences that reached statistical signifi- 
cance at the genus level between unaffected (0) and affected (1) 


































d  ococcaceae IncertaeSedis (AP p = 0.025, FC = 0.24), Ruminococcaceae In-
ertaeSedis (AP p = 0.036, FC = 0.37), Acidaminococcus (AP p = 0.0028,
C = 0.60), Haemophilus (AA p = 0.078, FC = 0.035). 
.3. Analysis of differences in diversity and richness 
There was no significant difference in microbiota diversity when
rouping by affected vs. unaffected ( p = 0.19) or when grouping
nto unaffected, affected without psychosis and affected with psychosis
 p = 0.37). When grouping the individuals into two groups (U and A),
e found that richness was decreased by trend ( p = 0.08) among af-
ected participants but the finding did not reach significance. The dif-
erence was not significant when grouping the paired siblings into the
hree groups of unaffected, affected without psychosis and affected with
scyhosis ( p = 0.22). 
.4. Analysis of differences in the predicted functions of the gut microbiota 
Significant differences in the predicted functional potential of the gut
icrobiota between different study groups were identified ( p < 0.05),5  Figs. 4–6 ). Several pathways related to amino acid and fatty acid
etabolism were significantly enriched in affected individuals ( Fig. 4 ).
he 3-group comparison revealed that the pathways related to amino
cid metabolism, especially tryptophan biosynthesis, were significantly
levated in individuals with psychosis ( Fig. 6 ). No difference in the pre-
icted functions of the gut microbiota was observed between unaffected
ndividuals and individuals affected without psychosis. 
. Discussion 
We compared the gut microbiota of individuals with serious men-
al disorders to their healthy siblings and found significant differences
n the abundance of bacterial taxa and predicted functions of the mi-
robiota. To our knowledge, this is the first comparative study on the
ut microbiota in individuals with mental disorders in Latin American
opulations, and one of the first to use sibling cohort for comparative
icrobiota study between cases and controls in any patient group. In
ddition to inbuild adjustment for genetic relatedness, common life his-
ory and largely shared diet and other environmental exposures, we ad-
itionally took extra effort to identify co-variates for the microbiota that
S. Ouabbou, C. Jian, A. Ávila-Aguirre et al. Journal of Affective Disorders Reports 4 (2021) 100081 
Fig. 3. Compositional differences that reached statistical significance at the genus level affected without psychosis (1) and affected with psychosis (2) compared to 





































ight confound the analyses. Somewhat surprisingly we found that two
rugs, levothyroxine, used to treat hypothyroidism, and irbesartan, an
ngiotensin receptor II antagonist that is used as an antihypertensive,
ere strongly associated to microbiota variation, necessitating their use
s confounders in the analyses. To our knowledge this is the first time
evothyroxine or angiotensin II receptor antagonists have been reported
o have an impact on the makeup of the gut microbiota. Interestingly, a
revious study identifies levothyroxine use as a risk factor for small in-
estinal bacterial overgrowth ( Brechmann et al., 2017 ). Our findings call
or further studies on this topic and in general stress the importance of
ncluding all regular medication as a covariate in gut microbiota studies.
reviously, drugs like metformin ( Maier et al., 2018 ) or antipsychotics
 Davey et al., 2012 ; Bahr et al., 2015 ) have been shown to influence the
ut microbiota composition, which we did not observe in the present
tudy. 
Formal psychiatric diagnoses, as described in the DSM, are phe-
omenological and have little correlation with the biological patho-
hysiology of the disorder, providing a rationale for studying clusters6 f symptoms by grouping together disorders that share genes and symp-
oms rather than focusing on the specific diagnoses ( Tamminga et al.,
013 ). In our small cohort of siblings, we therefore grouped several
ajor psychiatric disorders into categories such as “affected ”, “affected
ith psychosis ” or “affected without psychosis ”. This approach identi-
ed several differences in the gut microbiota between the affected and
naffected siblings ( Figs. 2–6 , Tables 4–5) that are discussed below. 
Overall, our results indicate that most of the implicated taxa had
ower relative abundance in affected versus unaffected individuals
Tables 4–5). This is in line with the recent systematic review and
eta-analysis on the gut microbiota in major depressive disorder,
 Sanada et al., 2020 ) however the taxa that the review identified as
ltered in at least two independent studies (e.g. Faecalibacterium, Pre-
otella ) were different from the ones identified as altered in the cur-
ent study on Latin Americans. Similarly to the above-mentioned meta-
nalysis, we did not find significant decrease in the richness or diversity
f the microbiota in affected individuals although in both studies there
as a trend for decreased richness compared to healthy controls. 
S. Ouabbou, C. Jian, A. Ávila-Aguirre et al. Journal of Affective Disorders Reports 4 (2021) 100081 
Fig. 4. Differences in the functional potential of the microbiota between U and A. 
Fig. 5. Differences in functional potential of the gut microbiota between AP and UA. 
















































t  In our cohort the largest difference in terms of fold change, almost
0-fold increase, was observed for genus Pseudomonas. Pseudomonas are
enerally considered to be pathogenic bacteria and were previously re-
orted to be elevated in patients with depression ( Huang et al., 2018 )
nd schizophrenia ( Maes et al., 2018 ). As gram-negative bacteria, Pseu-
omonas contain lipopolysaccharide (LPS) on their cell wall, which is a
ro-inflammatory molecule ( Pier, 2007 ). Our finding on increased Pseu-
omonas in affected individuals is therefore largely in accordance with
he previous studies mentioned. 
Ruminococcaceae and Lachnospiraceae are the two most dominant
acterial families in the human gut microbiota. Ruminococcaceae con-
ains several butyrate producers and are hence generally considered as
eneficial bacteria. A previous study found decreased in bipolar patients
uring depressive episodes ( Painold et al., 2019 ). Clostridiaceae have
een described as bacteria that participate in maintaining a healthy gut
arrier and gut-associated immune system ( Velasquez-Manoff, 2015 ).
ur finding of a decrease in Clostridiaceae in affected individuals with
sychosis is in line with these previous observations ( Sanada et al.,
020 ). 
Veillonellaceae (mainly Megasphaera ) was enriched in the abundance
n affected siblings compared to the unaffected. Megasphaera has been
escribed to have anti-inflammatory activity and be neuroprotective
 Ahmed et al., 2019 ). A few studies suggest that Megasphaera is as-
ociated with mental health, yet the mechanism remains unknown7  Ahmed et al., 2019 ). Porphyromonadaceae have been found to be neg-
tively correlated with cognition in elderly humans ( Bajaj et al., 2016 ).
n the present study we found significant decreases in the relative abun-
ance of several genera within Porphyromonadaceae , including Barne-
iella, Odoribacter and Paludibacter . The role of Barnesiella ( Sakamoto
t al., 2007 ) in the human gut ecosystem is poorly known, but it is gener-
lly associated with healthy outcomes ( Ubeda et al., 2013 ; Daillère et al.,
016 ) and was reported as depleted in patients with depression. Similar
ecal microbiota signatures have been found in patients with diarrhea-
redominant irritable bowel syndrome and patients with depression
 Liu et al., 2016 ). Comparably, the role of Odoribacter in the gut mi-
robiota remains largely unclear, while it is thought to promote healthy
arrier function of the gut ( González-sarrías et al., 2018 ). Odoribacter
as found more abundant in a transgenic mouse model of Alzheimer’s
isease compared to a wild type strain of mice ( Shen et al., 2016 ). It
s of particular interest that Barnesiella was found dose-dependently de-
reased according to the severity of the state of being affected (Table 5),
ndividuals without psychosis had the highest and those affected with
sychosis the lowest levels of Barnesiella . 
Our results show that there is a significant decrease in the abun-
ance of oxygen-tolerant Streptococcaceae in affected compared to un-
ffected which contradicts previous studies in depressed individuals
 Nguyen et al., 2018 ; Lin et al., 2017 ). On the other hand, the rela-
ive abundance of Lactoccocus was increased in individuals affected with

















































































































G  sychosis compared to unaffected siblings. Finally, among the Pasteurel-
aceae, Haemophilus has previously been documented to be decreased in
chizophrenia ( Nguyen et al., 2019 ) which is in line with our results. 
The intestinal bacteria are highly individualized on compositional
evel, providing evolutionarily advantageous functional redundancy
 Heintz-Buschart and Wilmes, 2018 ). Therefore, knowing the taxonomic
omposition provides little information regarding the functions involved
n microbiota-host interaction. Few previous studies have investigated
unctional profiles of the gut microbiota between affected and unaf-
ected individuals ( Shen et al., 2018 ; Nguyen et al., 2019 ). Here we used
 computational approach that utilizes 16S rRNA data to predict the
unctional composition of a metagenome. In line with the existing stud-
es ( Pe ł ka-Wysiecka et al., 2019 ; Shen et al., 2018 ), several pathways
elated to amino acid metabolism were significantly elevated in individ-
als affected with mental disorders, especially in individuals affected
ith psychosis. Changes in glycine, serine and threonine metabolism
ave been reported to be associated with treatment-resistant depression
 Maes et al., 1998 ). The branched-chain amino acids (BCAAs) valine,
eucine and isoleucine have been proposed to be novel biomarkers for
epression ( Baranyi et al., 2016 ) and were increased peripherally in pa-
ients with schizophrenia in some studies ( De Luca et al., 2008 ). Changes
n tryptophan metabolism, which can be modulated by the gut micro-
iota ( O’Mahony et al., 2015 ), are believed to be involved in the patho-
enesis of psychiatric disorders ( Gostner et al., 2020 ). In summary, our
ndings suggest that altered amino acid metabolism in the gut micro-
iota is associated with serious mental disorders. 
The main strengths of this study are the carefully screened partici-
ants and their matching siblings, which reduces potential noise aris-
ng from genetic or environmental factors. Imputed metagenomics that
omplements our taxonomic analysis provides additional information
ith regards to the specific metabolic pathways potentially involved in
ost-microbiota interactions relevant for mental health. 
Limitations of our study include small sample size and the cross-
ectional design. Indeed, the small size of the sample limits its statisti-
al power and makes it more vulnerable to confounding factors. There
s also the matter of the limited uniformity of the sample. Although nu-
erous confounding factors were utilized in the PERMANOVA, a more
niform sample would have been desirable. Finally, the cross-sectional
esign of the study does not allow for the establishment of causality
nd its directionality. Future longitudinal studies with larger cohorts
re warranted to confirm the findings from our study, such as changes
n amino acid metabolism of the gut microbiota in individuals affected
ith mental disorders, which may represent novel therapeutic options. 
In conclusion, our results recapitulate several observations made by
revious studies, such as increased LPS-producing Pseudomonas and re-
uced proportions of butyrate producing Ruminococcaceae in affected
ndividuals. We also identified novel associations between serious men-
al disorders and the low-abundant genera Barnesiella and Odoribacter .
he changes in the taxonomic composition of the gut microbiota may
ontribute to altered amino acid metabolism, which has been implicated
n several psychiatric disorders. Taken together, our study adds to the
urrent evidence on the importance of the gut-brain axis in the patho-
hysiology of serious mental disorders. 
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